Biotech Values

[mcbio]

If GS-7977/Riba has viral relapse problems in GT1 treatment-naive patients it could be a wildly bullish event for Medivir.

When are these results due?

Positive data for 7977/Riba in GT1's shouldn't cause significant downside for Medivir so in this respect it would be good trade IMO.

I'm inclined to agree because I think the goal is to ultimately remove riba as well. I think this is another reason why the 7977+TMC435 combo study is so important because they are testing both drugs with and without riba (http://www.medivir.se/v4/en/ir_media/pressrelease.cfm?year=2011&releaseid=587686 ).